Lunit
Lunit is dedicated to saving lives through innovative technology by developing AI solutions for cancer detection and treatment. Their mission is to improve cancer care worldwide by leveraging AI to enable early detection, accurate prediction of treatment response, and expanding access to cancer diagnostics and therapy. With a strong research focus, numerous awards, and a global network of partners and users, Lunit aims to advance precision oncology and make cancer care more effective and accessible.
Industries
Nr. of Employees
large (251-1000)
Patents
Method and system for predicting expression of biomarker from medical image
US-12340513-B2
View DetailsMethod for discriminating suspicious lesion in medical image, method for interpreting medical image, and computing device implementing the methods
US-12217425-B2
View DetailsMethod for managing annotation job, apparatus and system supporting the same
US-12217853-B2
View DetailsMethod and system for predicting expression of biomarker from medical image
US-12136218-B2
View Details
Method and system for predicting expression of biomarker from medical image
US-12340513-B2
View DetailsMethod for discriminating suspicious lesion in medical image, method for interpreting medical image, and computing device implementing the methods
US-12217425-B2
View DetailsMethod for managing annotation job, apparatus and system supporting the same
US-12217853-B2
View DetailsMethod and system for predicting expression of biomarker from medical image
US-12136218-B2
View DetailsProducts
Chest X‑ray AI analysis software
Software that analyzes chest radiographs to detect abnormalities relevant to cancer screening and thoracic disease screening; designed for clinical deployment and mass screening operations.
AI-derived biomarker for immunotherapy response
Software that produces imaging-based biomarkers to predict patient response to immunotherapy, intended to inform oncology treatment decisions.
Chest X‑ray AI analysis software
Software that analyzes chest radiographs to detect abnormalities relevant to cancer screening and thoracic disease screening; designed for clinical deployment and mass screening operations.
AI-derived biomarker for immunotherapy response
Software that produces imaging-based biomarkers to predict patient response to immunotherapy, intended to inform oncology treatment decisions.
Services
Partnerships with hospitals and academic centers to conduct clinical studies, generate publications, and validate AI algorithms in clinical settings.
Implementation and integration of AI screening software into clinical workflows, including configuration with imaging systems and operational support for large-scale screening programs.
Partnerships with hospitals and academic centers to conduct clinical studies, generate publications, and validate AI algorithms in clinical settings.
Implementation and integration of AI screening software into clinical workflows, including configuration with imaging systems and operational support for large-scale screening programs.
Expertise Areas
- AI for medical imaging
- Imaging-derived biomarker development
- Clinical validation and publication
- Large-scale screening program deployment
Key Technologies
- Deep learning for medical imaging
- Medical image analysis (chest X-ray, whole-slide pathology)
- AI-driven biomarker prediction
- Cloud-based deployment and scaling
News & Updates
Jul 2, 2025 - 3 min read
Jun 13, 2025 - 3 min read
May 28, 2025 - 4 min read
Ranked 1st place in CAMELYON Grand Challenge 2017
Jul 2, 2025 - 3 min read
Jun 13, 2025 - 3 min read
May 28, 2025 - 4 min read